Nanomedicine and Life Sciences Companies

Accelr8 Technology Corporation is a developer of innovative materials and instrumentation for advanced applications in medical diagnostics, basic research, drug discovery, and bio-detection. Accelr8 is developing a new diagnostic platform, the BACcelr8r?, based on its proprietary surface coatings, assay processing, and detection technologies.

Accium offers laboratory services based on its Accelerator Mass Spectrometry platform used to detect 14C/12C ratios which provided 1,000 times more sensitivity than the most sensitive method available today such as LC/MS. It is now possible to trace biomolecule delivery in healthy subjects with low attomole (10-18M) sensitivity.

The company has developed and produced superparamagnetic nanoparticles for in vitro diagnostic and life sciences.

The Advalytix chip-technology builds on nanopumps that need no moving parts to manipulate reagents measured by the billions of a liter for single cell assays.

Developer, manufacturer and distributor of innovative sample preparation devices for high sensitive mass spectrometry and liquid chromatography.

Digital microfluidics is a lab-on-a-chip approach based on direct, programmable micromanipulation of nanoliter volume droplets using electrical fields. Digital microfluidics enables complex, multi-step liquid handling protocols to be flexibly, scalably, and cost effectively implemented.

Develops and to markets a novel, automated chip-based technology for mass spectrometry users with the microfluidics chip containing an array of nanoelectrospray nozzles.

Affymetrix GeneChip microarray technology is the industry-standard tool for analyzing complex genetic information. The GeneChip solution consists of oligonucleotide arrays, instruments to process and analyze the arrays, and software tools to manage and mine the data.

Agave BioSystems harnesses the extreme specificity and sensitivity of biological systems to build unique and useful nanoscale engineered devices and systems for diagnostic and analyical applications.

The company develops Rapid Early Detection products. These products identify possible pathological threats from bioterrorism to pathogens plaguing global agriculture, animals and people. Test arrays include nanoscale molecule detection techniques.

AION has focused on development of early stage diagnostics based on its nano-scale platform; modified porous silicon (mpSi).

A nano-biotechnology company with a nanoscale drug discovery technique for systematically scanning 'molecular diversity space'. The company has also developed technology for molecular manufacturing.

AlphaSniffer LLC has developed a highly-sensitive biosensor for detection of trace amounts (pg/mm2) of bacteria, viruses, proteins, nucleic acids, antibodies and other biological and chemical agents in real-time. The unique patented biosensor design relies upon the common path interferometric detection principle in combination with the surface plasmon resonance effect.

Ambri's technology is a novel biosensor technology based upon a synthetic self assembling membrane. The membrane acts like a biological switch and is capable of detecting the presence of specific molecules, and signalling their presence by triggering an electrical current.

ANT has strategic focus in the research, development and manufacture of real time and near real time diagnostics to detect biochemical discharges in manufacturing and environmental situations. The company currently concentrates on the following biochemical detection systems: Enzymes, Dioxins, Estrogen Steroids.

AnaSpec, Inc. is a leading provider of integrated proteomics solutions for worldwide life science research. With a vision for innovation through synergy, AnaSpec offers expertise in three primary technologies: peptides, detection reagents, and combinatorial chemistry. AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. In conjunction, AnaSpec provides premier custom services including peptide synthesis, antibody production, and assay development.

ANP's mission is to develop cutting-edge technology platforms at the nano/bio interface and apply them in market sectors such as diagnostics/biodetection, protein/drug discovery, therapeutics, chem/bio defense, and homeland security.

A medical biosensor device company that is developing a non-invasive monitor to measure exhaled nitric oxide for management of asthma.

Develops a innovative detection and monitoring process referred to as Life Sciences at Speed of Light (LSSL). LSSL integrates a number of well-defined procedures in a proprietary and innovative manner that allows for significant technical advantages over existing biomarker detection and monitoring techniques as well as dramatic cost-savings on a per biomarker basis.

The core of the company's product line is their proprietary Diffractive Optics Technology - or dot™ - which combines two proven technologies - the diffraction of light and immobilized capture surfaces - to provide a simple, sensitive, and cost-effective technique for the real-time detection of biomolecular interactions and immunoassays without the use of labels.

Manufactures gold colloid particles for use in immuno conjugates.

Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum – from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing – Beckman Coulter's 200,000 installed systems provide essential biomedical information to enhance health care around the world.

The company produces BioPixels™, semiconductor-based, nanocrystalline fluorescent markers for cell and intracellular detection and analysis.

As a manufacturer of nanoliter dispensing equipment, BioDot has had extensive experience with the development BioDot is the leading supplier of system tools for the research, development and commercialization of diagnostic tests. As a manufacturer of nanoliter dispensing equipment, BioDot has had extensive experience with the development of manufacturing processes for the protein array industry.

Developer of ultra-miniaturized nanoarray technologies. Molecular analysis systems are capable of providing nanometer scale, single molecule resolution. Applications in proteomics, diagnostics, and therapeutics.